Showing results (1761-1770 of 1,858) with videos related to
Sort By:
Pageof 186
AIDS Care|May 29, 2018
The people living with HIV stigma survey UK 2015: HIV-related sexual rejection and other experiences of stigma and discrimination among gay and heterosexual menM Hibbert, W Crenna-Jennings, P Kirwan, et al.Oncotarget|December 6, 2022
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patientsYehia I Mohamed, Dan G Duda, Muhammad O Awiwi, et al.Plos One|August 12, 2021
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) settingKara Magee, Ian R Marsh, Michelle M Turek, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control studyRuth L Katz, Weigong He, Abha Khanna, et al.Hepatology (Baltimore, Md.)|September 15, 2020
HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma RiskJeffrey S Morris, Manal M Hassan, Ye Emma Zohner, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 15, 2024
Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients - A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomiaGrace C Blitzer, Cristina Paz, Annemarie Glassey, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular SubtypesJonathan M Loree, Allan A L Pereira, Michael Lam, et al.Antimicrobial Agents and Chemotherapy|January 20, 2000
Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitorsJ Onishi, M Meinz, J Thompson, et al.The British Journal of Dermatology|August 25, 2015
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelinesJ E Mellerio, S J Robertson, C Bernardis, et al.Blood|April 17, 2009
Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administrationRachel D Kuns, Edward S Morris, Kelli P A Macdonald, et al.Pageof 186